The role of human tissue kallikreins 7 and 8 in intracranial malignancies

dc.contributor.authorPrezas, P.en
dc.contributor.authorScorilas, A.en
dc.contributor.authorYfanti, C.en
dc.contributor.authorViktorov, P.en
dc.contributor.authorAgnanti, N.en
dc.contributor.authorDiamandis, E.en
dc.contributor.authorTalieri, M.en
dc.date.accessioned2015-11-24T19:30:15Z
dc.date.available2015-11-24T19:30:15Z
dc.identifier.issn1431-6730-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23054
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectBase Sequenceen
dc.subjectBrain Neoplasms/pathology/*physiopathologyen
dc.subjectDNA Primersen
dc.subjectHumansen
dc.subjectMiddle Ageden
dc.subjectTissue Kallikreins/*physiologyen
dc.titleThe role of human tissue kallikreins 7 and 8 in intracranial malignanciesen
heal.abstractRecent evidence suggests that many tissue kallikreins are implicated in carcinogenesis. Kallikrein 8 (KLK8) plays a role in the physiology of the central nervous system. Kallikrein 7 (KLK7) takes part in skin desquamation. Both show altered expression in ovarian and breast cancer. In this study, we examined the level of mRNA expression of the KLK7 and KLK8 genes in 73 intracranial tumors using qualitative RT-PCR. The results were correlated with clinical and histomorphological variables and patient outcome. The expression of both genes was also examined in the brain cancer cell lines U-251 MG, D54 and SH-SY5Y and the invasive capacity of glioblastoma cells U-251 MG overexpressing hK7 or hK8 was also investigated in an in vitro Matrigel assay. Follow-up analysis revealed that expression of KLK7 mRNA was associated with shorter overall survival (OS) compared to patients with no KLK7 expression, as determined by Cox proportional hazard regression analysis. Overexpression of hK7 protein by cultivated brain tumor cells significantly enhanced the invasive potential in the Matrigel invasion assay, in contrast to cells overexpressing hK8 protein. Our data suggest that hK7 protein overexpression is associated with a more aggressive phenotype in brain cancer cells.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1515/BC.2006.200-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17132107-
heal.identifier.secondaryhttp://www.degruyter.com/dg/viewarticle.fullcontentlink:pdfeventlink/contentUri?t:ac=j$002fbchm.2006.387.issue-12$002fbc.2006.200$002fbc.2006.200.xml-
heal.journalNameBiol Chemen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2006-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Πρωτότυπος φάκελος/πακέτο

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
Prezas-2006-The role of human ti.pdf
Μέγεθος:
104.16 KB
Μορφότυπο:
Adobe Portable Document Format

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: